MOSCOW, February 7. /TASS/. The Russian Direct Investment Fund (RDIF) expects that Russia’s Sputnik V COVID-19 vaccine will be registered in 25 countries by the end of next week, the sovereign wealth fund’s CEO Kirill Dmitriev told Vesti Nedeli program on Rossiya-1 TV channel.
"By the end of next week we expect that a total of 25 regulators, 25 countries will approve our vaccine [Sputnik V]," Dmitriev said.
To date, Russia’s coronavirus vaccine has been approved by 19 regulators, Dmitriev said.
Earlier, The Lancet published the results of the Phase Three clinical trials of Russia’s Sputnik V coronavirus vaccine according to which it is one of the safest and most effective ones worldwide. The efficiency of the vaccine amounted to 91.6%, and among volunteers aged over 60 it came to 91.8%. Antibodies to coronavirus after taking the Sputnik V jab were detected in 98% of volunteers.